Oncology

A temperature tested photonic crystal sensor achieves over 91% accuracy in cervical cancer screening using label free optical detection.

A new water jet surgical device combines cutting and anaesthesia, reducing tissue injury and allowing precise drug delivery.

Metastatic ILC shows significant biomarker heterogeneity, limiting single biopsy reliability and highlighting challenges in detection and monitoring.

Breast cancer survivors with high genetic risk for excess body weight had 15% higher mortality, and required more weekly walking to mitigate inherited risk.

Phase two data show Elenagen combined with gemcitabine significantly prolongs overall survival in platinum resistant ovarian cancer without added safety concerns.

A Phase three trial shows early immunochemotherapy significantly improves survival and enhances CD8 T cell responses in advanced non small cell lung cancer.

Large cohort study shows GLP-1 receptor agonists combined with progestins lower endometrial cancer risk and reduce hysterectomy incidence in women with benign uterine disease.

Phase 2 findings show neoadjuvant pembrolizumab produced a 71% pathological complete response rate in resectable desmoplastic melanoma, with favourable safety and three year follow up outcomes.